Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Correlations between seru… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Correlations between serum and CSF pNfH levels in ALS, FTD and controls: A comparison of three analytical approaches

Artikel i vetenskaplig tidskrift
Författare C. Wilke
Fani Pujol-Calderón
C. Barro
E. Stransky
Kaj Blennow
Z. Michalak
C. Deuschle
A. Jeromin
Henrik Zetterberg
R. Schüle
Kina Höglund
J. Kuhle
M. Synofzik
Publicerad i Clinical Chemistry and Laboratory Medicine
Volym 57
Nummer/häfte 10
Sidor 1556–1564
ISSN 1434-6621
Publiceringsår 2019
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Sidor 1556–1564
Språk en
Länkar dx.doi.org/10.1515/cclm-2019-0015
Ämnesord amyotrophic lateral sclerosis (ALS), cerebrospinal fluid (CSF), frontotemporal dementia (FTD), phosphorylated neurofilament heavy chain (pNfH), serum, single molecule array (Simoa)
Ämneskategorier Klinisk kemi

Sammanfattning

Phosphorylated neurofilament heavy (pNfH), a neuronal cytoskeleton protein, might provide a promising blood biomarker of neuronal damage in neurodegenerative diseases (NDDs). The best analytical approaches to measure pNfH levels and whether serum levels correlate with cerebrospinal fluid (CSF) levels in NDDs remain to be determined. We here compared analytical sensitivity and reliability of three novel analytical approaches (homebrew Simoa, commercial Simoa and ELISA) for quantifying pNfH in both CSF and serum in samples of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and control subjects. While all three assays showed highly correlated CSF measurements, Simoa assays also yielded high between-assay correlations for serum measurements (± = 0.95). Serum levels also correlated strongly with CSF levels for Simoa-based measurements (both ± = 0.62). All three assays allowed distinguishing ALS from controls by increased CSF pNfH levels, and Simoa assays also by increased serum pNfH levels. pNfH levels were also increased in FTD. pNfH concentrations in CSF and, if measured by Simoa assays, in blood might provide a sensitive and reliable biomarker of neuronal damage, with good between-assay correlations. Serum pNfH levels measured by Simoa assays closely reflect CSF levels, rendering serum pNfH an easily accessible blood biomarker of neuronal damage in NDDs. ©2019 Walter de Gruyter GmbH, Berlin/Boston.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?